Skip to content
PepIndex

Certificate record

Semaglutide, lot 2122026SM

Vanguard Laboratory assayed lot 2122026SM of Semaglutide from Prime Peptides at 99.02% purity on 25 Mar 2026, reporting 5.51 mg against a 5 mg label, 10.2% above the labelled mass.

Assayed 25 Mar 2026 · Vanguard Laboratory · Prime Peptides · record id coa-primepeptides-2122026sm

What the certificate reports

CompoundSemaglutide
Lot identifier2122026SM
Purity99.02%
Labelled mass5 mg
Assayed mass5.51 mg
Difference10.2% above the label
Assay date25 Mar 2026
Testing laboratoryVanguard Laboratory
Who commissioned itPublished by the vendor. Scored as a claim, not as corroboration — only an independently commissioned assay counts as verified.
Source documenthttps://primepeptides.co/wp-content/uploads/2026/04/Semaglutide-5mg-March-Test-VANGUARD.pdf

Check it yourself

Vanguard Laboratory does not publish a public lookup we have been able to find, so this certificate can be read but not independently re-pulled from the laboratory. The document above is the copy the vendor published. Where a laboratory does offer a lookup, we say so and link it.

A certificate describes the sample it names and nothing else. It is not a statement about any other lot, and it is not an endorsement of the vendor or of any use of the material.

Other lots from Prime Peptides

Semaglutide from other vendors